{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:45:58Z","timestamp":1781210758965,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.clinbiochem.2006.05.002","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:17Z","timestamp":1148109737000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes"],"prefix":"10.1016","volume":"39","author":[{"given":"Jair A.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sevanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Apolin\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulcineia S.P.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2006.05.002_bib1","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib3","doi-asserted-by":"crossref","first-page":"18C","DOI":"10.1016\/S0002-9149(99)80466-4","article-title":"Pathogenesis of atherosclerosis. A symposium: cholesterol-lowering trials: new results and emerging issues","volume":"76","author":"Navab","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib4","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-2275(20)41181-2","article-title":"Biochemical and citotoxic characteristic of an in vivo circulating oxidized low density lipoprotein (LDL\u2212)","volume":"35","author":"Hodis","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000014762.06201.06","article-title":"Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?","volume":"105","author":"Steinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.103.15.1930","article-title":"Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk","volume":"103","author":"Tsimikas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib13","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0021-9150(97)00305-5","article-title":"Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis","volume":"137","author":"Holvoet","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-2952(98)00074-4","article-title":"Oxidized low-density lipoprotein, a two-faced janus in coronary artery disease","volume":"56","author":"Parthasarathy","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib15","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0021-9150(97)06115-7","article-title":"A critical look at the evidence for the oxidation of LDL in atherogenesis","volume":"131","author":"Steinberg","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib16","first-page":"79","article-title":"Presence of a modified low density lipoprotein in humans","volume":"8","author":"Avogaro","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.ATV.16.7.831","article-title":"The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff memorial lecture","volume":"16","author":"Navab","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0891-5849(96)00626-0","article-title":"Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein","volume":"23","author":"Chang","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.ATV.16.6.773","article-title":"A cytotoxic electronegative ldl subfraction is present in human plasma","volume":"16","author":"Demuth","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.ATV.16.6.784","article-title":"Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations","volume":"16","author":"Sevanian","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-2275(20)37250-3","article-title":"LDL- is a lipid hydroperoxide-enriched circulating lipoprotein","volume":"38","author":"Sevanian","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00041433-200406000-00014","article-title":"Electronegative low density lipoprotein","volume":"15","author":"S\u00e1nches-Quesada","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0891-5849(91)90120-R","article-title":"Characterization of a more electronegatively charged LDL subfraction by exchange HPLC","volume":"11","author":"Cazzolato","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib24","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0891-5849(99)00008-8","article-title":"Presence of aldheidic epitopes on a minor low-density lipoprotein fraction","volume":"26","author":"Greilberger","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000014378","article-title":"Low density lipoprotein (LDL) modification: basics concepts and relationship to atherosclerosis","volume":"17","author":"Sevanian","year":"1999","journal-title":"Blood Purif"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","article-title":"The role of oxidized lipoproteins in atherogenesis","volume":"20","author":"Berliner","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(01)00098-6","article-title":"Evidence for a role of phospholipid oxidation products in atherogenesis","volume":"11","author":"Berliner","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.01-0273rev","article-title":"Oxidized LDL and HDL: antagonists in atherotrombosis","volume":"15","author":"Mertens","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00041433-200208000-00003","article-title":"Oxidized lipids as mediators of coronary heart disease","volume":"13","author":"Navab","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of the joint European Society of Cardiology\/American College of Cardiology Committee for the Redefinition of Myocardial","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib31","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.99.21.2829","volume":"99","author":"Gibbons","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(90)90131-2","article-title":"Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation","volume":"83","author":"Griffin","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib33","series-title":"Fundamentals of biostatistics","author":"Rosner","year":"1995"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0002-9149(01)01613-7","article-title":"Measurement of plasma lipids in patients admitted with acute myocardial infarction or unstable angina pectoris","volume":"88","author":"Rauoof","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0021-9150(98)00242-1","article-title":"Upregulation of cholesterol synthesis after acute myocardial infarction\u2014is cholesterol a positive acute phase reactant?","volume":"142","author":"Pfhol","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9149(01)02270-6","article-title":"Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction","volume":"89","author":"Barbagallo","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9150(01)00527-5","article-title":"Earlier decrease in plasma lipids than increase in C-reactive protein during very acute phase of myocardial infarction","volume":"156","author":"Kawano","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2004.05.026","article-title":"Decrease of plasma triglycerides during the acute phase of unstable angina or no-ST elevation myocardial infarction is a marker of recurrent ischemia","volume":"177","author":"Correia","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00268-003-7399-4","article-title":"Redox process underlying the vascular repair reaction","volume":"28","author":"Leite","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2005.10.005","article-title":"Impact of oxidized low density lipoprotein on vascular cells","volume":"185","author":"Galle","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib41","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increase in oxidized phospholipids and lipoprotein (a). Short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(99)00218-X","article-title":"Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects","volume":"148","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"issue":"Suppl. III","key":"10.1016\/j.clinbiochem.2006.05.002_bib43","first-page":"III-2","article-title":"Atherogenic lipoprotein particles in atherosclerosis","volume":"109","author":"Carmena","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib44","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?","volume":"110","author":"Shoenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","article-title":"Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes","volume":"41","author":"Tsimikas","year":"2003","journal-title":"J Am Coll Cardiol Found"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib46","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/circ.104.13.1454","article-title":"Cardiac biomarkers for rapid evaluation of chest pain","volume":"104","author":"Hamm","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clinbiochem.2006.05.002_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Mechanisms of disease: acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib49","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days. An effect independent of low-density lipoprotein cholesterol reduction","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0009-9120(00)00186-7","article-title":"High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy","volume":"33","author":"Yu","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.CIR.0000053731.05365.5A","article-title":"Coming of age of C-reactive protein. Using inflammation markers in cardiology","volume":"107","author":"Yeh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0735-1097(00)01199-2","article-title":"Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease","volume":"37","author":"Inoue","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. II","key":"10.1016\/j.clinbiochem.2006.05.002_bib53","first-page":"II-2","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.amjcard.2003.11.017","article-title":"Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris","volume":"93","author":"Young-Cheoul","year":"2004","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2006.05.002_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/000331970205300303","article-title":"Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile","volume":"53","author":"Jian-Jun","year":"2002","journal-title":"Angiology"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib56","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.ATV.0000149378.98458.fe","article-title":"Reduced in vivo aortic uptake of radiolabeled oxidation-specifics antibodies reflects changes in plaque composition consistent with plaque stabilization","volume":"24","author":"Torzewski","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib57","first-page":"53","article-title":"PET\/CT for atherosclerotic plaque imaging","volume":"50","author":"Ben-Haim","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib58","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2005.09.075","article-title":"Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive modalities. The integrated biomarker and imaging study (IBIS)","volume":"47","author":"Van Mieghem","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2006.05.002_bib59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0021-9150(96)05888-1","article-title":"Preparation and biodistribution of 99\u00a0m technetium labeled oxidized LDL in man","volume":"126","author":"Iuliano","year":"1996","journal-title":"Atherosclerosis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200600155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200600155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:23:56Z","timestamp":1757863436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991200600155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S000991200600155X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.05.002","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}